Thrivent Financial for Lutherans lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 380,476 shares of the medical equipment provider’s stock after selling 934 shares during the period. Thrivent Financial for Lutherans owned about 0.11% of Intuitive Surgical worth $186,917,000 at the end of the most recent quarter.
A number of other institutional investors have also bought and sold shares of ISRG. Creekmur Asset Management LLC boosted its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. LRI Investments LLC purchased a new stake in Intuitive Surgical during the 1st quarter valued at approximately $30,000. Finally, LGT Financial Advisors LLC raised its position in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Price Performance
Shares of NASDAQ ISRG opened at $527.61 on Friday. The company has a market cap of $187.92 billion, a P/E ratio of 84.82, a PEG ratio of 5.19 and a beta of 1.39. The firm has a 50-day simple moving average of $499.29 and a two-hundred day simple moving average of $457.89. Intuitive Surgical, Inc. has a 1 year low of $295.02 and a 1 year high of $544.38.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on ISRG shares. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird increased their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Citigroup lifted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. BTIG Research set a $535.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Finally, Stifel Nicolaus lifted their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.
Read Our Latest Stock Report on Intuitive Surgical
Insider Activity
In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. This trade represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The trade was a 93.06 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 91,178 shares of company stock valued at $45,897,071. 0.90% of the stock is currently owned by company insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- EV Stocks and How to Profit from Them
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Where to Find Earnings Call Transcripts
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.